ACAD vs AWK
ACADIA Pharmaceuticals Inc (ACAD) versus American Water Works (AWK) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Latest reported ACAD revenue for 2024-12-31 was $957.8M. Net income was $226.5M. Revenue was up 314.6% from 2023-12-31 to 2024-12-31. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Not investment advice. Open the ACAD and AWK stock pages for the full models.
Not investment advice.